1. Home
  2. HUDI vs MRKR Comparison

HUDI vs MRKR Comparison

Compare HUDI & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUDI
  • MRKR
  • Stock Information
  • Founded
  • HUDI 2018
  • MRKR N/A
  • Country
  • HUDI China
  • MRKR United States
  • Employees
  • HUDI N/A
  • MRKR N/A
  • Industry
  • HUDI Steel/Iron Ore
  • MRKR Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUDI Industrials
  • MRKR Health Care
  • Exchange
  • HUDI Nasdaq
  • MRKR Nasdaq
  • Market Cap
  • HUDI 23.1M
  • MRKR 21.9M
  • IPO Year
  • HUDI 2021
  • MRKR N/A
  • Fundamental
  • Price
  • HUDI $1.57
  • MRKR $1.57
  • Analyst Decision
  • HUDI
  • MRKR Strong Buy
  • Analyst Count
  • HUDI 0
  • MRKR 1
  • Target Price
  • HUDI N/A
  • MRKR $19.00
  • AVG Volume (30 Days)
  • HUDI 32.0K
  • MRKR 95.6K
  • Earning Date
  • HUDI 02-28-2025
  • MRKR 03-25-2025
  • Dividend Yield
  • HUDI N/A
  • MRKR N/A
  • EPS Growth
  • HUDI N/A
  • MRKR N/A
  • EPS
  • HUDI 0.01
  • MRKR N/A
  • Revenue
  • HUDI $74,270,429.00
  • MRKR $5,395,849.00
  • Revenue This Year
  • HUDI N/A
  • MRKR $64.48
  • Revenue Next Year
  • HUDI N/A
  • MRKR N/A
  • P/E Ratio
  • HUDI $163.02
  • MRKR N/A
  • Revenue Growth
  • HUDI N/A
  • MRKR 79.04
  • 52 Week Low
  • HUDI $1.47
  • MRKR $1.48
  • 52 Week High
  • HUDI $3.45
  • MRKR $5.99
  • Technical
  • Relative Strength Index (RSI)
  • HUDI 43.70
  • MRKR 35.08
  • Support Level
  • HUDI $1.56
  • MRKR $1.53
  • Resistance Level
  • HUDI $1.74
  • MRKR $1.79
  • Average True Range (ATR)
  • HUDI 0.10
  • MRKR 0.18
  • MACD
  • HUDI 0.01
  • MRKR 0.03
  • Stochastic Oscillator
  • HUDI 30.93
  • MRKR 14.52

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

Share on Social Networks: